NCT Number: NCT03067051
Phase: Phase 1|Phase 2
Trial Summary: The rationale for the study is to obtain safety and efficacy data as well as to establish dose parameters for the SpectraCure P18 System with IDOSE®, with verteporfin for injection – clinicaltrials.gov for more information and locations
Clinicaltrials.gov
Trial Sponsor(s): SpectraCure AB
Acronym:
Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System
— PHENTrials.com Increasing Participation in Prostate Cancer Clinical Trials to Save Lives